Search - tctmd.com

Displaying 41 - 60 of 81

Sort: Relevancy | Date

Presentation The Structural Heart Disease Summit 2018

Keynote Lecture #1: New AS Classification Scheme Based on Cardiac Damage - Changes After AVR

Presenter: Philippe Genereux

June 22, 2018

Presentation The Structural Heart Disease Summit 2018

Mitral Annular Ring Dehisence Between Initial TTE and Pre-AVR Intraop TEE

Presenter: Isaac George, Christopher U. Meduri, Shahzad Shah, MD

June 22, 2018

Presentation The Structural Heart Disease Summit 2018

Surveying the Present and Future Landscape of AVR Therapy: A Patient-Centered Focus

Presenter: Daniel A Canos, Martin B. Leon, Vinod H. Thourani

June 21, 2018

Presentation

Valve-in-Valve TAVR vs Redo Surgical AVR for Bioprosthetic Aortic Valve Dysfunction

April 25, 2018

Presentation

Frailty in Older Adults Undergoing AVR:The FRAILTY-AVR Study

July 12, 2017

Presentation TVT 2017

Pitfalls in TAVR for Failing Stentless St. Jude Toronto 27mm Bioprosthetic AVR With Severe Aortic Insufficiency and No Significant Valvular Calcification

Presenter: Shigeru Saito, Jonathon M. White, Johannes Brechtken, MD

June 16, 2017

Presentation Miami Valves 2017

Case: 84 you Male with Porcine AVR 15 years ago and Moderate AR

Presenter: Zubin Agarwal

January 29, 2017

Presentation

Incidence and Consequence of Prosthesis-Patient Mismatch After Surgical AVR

Presenter: John Fallon

January 25, 2017

Presentation TCT 2016

Current Indications for TAVR: When Is TAVI Better Than Surgical AVR?

Presenter: Ziyad M. Hijazi, David W.M. Muller

November 01, 2016

Presentation TCT 2016

FFR in the setting of CABG and AS/AVR/TAVR

Presenter: Bernard De Bruyne, Allen Jeremias, Emanuele Barbato

November 01, 2016

Presentation TCT 2016

Debate: Should All Low-Risk Patients With Severe Aortic Stenosis Who are Suitable Be Allowed to Choose TAVR Rather than Surgical AVR, Without Further Trial Evidence? Con Position

Presenter: Niall T. Mulvihill, Hellmuth Weich

October 31, 2016

Presentation TCT 2016

Debate: Should All Low-Risk Patients With Severe Aortic Stenosis Who are Suitable Be Allowed to Choose TAVR Rather than Surgical AVR, Without Further Trial Evidence? Pro Position

Presenter: Niall T. Mulvihill, Antoniette Neylon

October 31, 2016

Presentation TCT 2016

Debate: TAVR for Low Risk Patients Is It time? NO, We Dont Yet Know if Its as Durable as Surgical AVR!

Presenter: Russell A. Brandwein, Isaac George

October 30, 2016

Presentation

Three-Year Outcomes in High-Risk Patients Who Underwent Surgical or Transcatheter AVR

Presenter: G. Michael Deeb

April 06, 2016

Presentation CTO 2016

Thats How I Do It: Antegrade Dissection/Reentry With a 6 French System

Presenter: Stéphane Rinfret, Simon J. Walsh, Alexandre Avran

February 25, 2016

Presentation

Outcome and Impact of AVR in Patients With Preserved LVEF and Low-Gradient Aortic Stenosis (AS)

Presenter: V. Dayan

December 06, 2015

Presentation Aortovascular 2015

Valve-in-Valve TAVR: Changing the approach to initial AVR surgery?

Presenter: Isaac George

September 19, 2015

Presentation Aortovascular 2015

Mechanical AVR and Root Replacement: When indicated?

Presenter: Michael Argenziano

September 19, 2015

Presentation Aortovascular 2015

Conventional AVR and Root Replacement: Bioprosthetic options

Presenter: Wilson Y. Szeto

September 19, 2015

Presentation TVT 2015

The Importance of Correct Valve Sizing in Surgical and Transcatheter AVR

Presenter: Jonathon A. Leipsic, Jeffrey J. Popma, Michael J. Reardon

June 05, 2015

Advertisement

Keynote Lecture #1: New AS Classification Scheme Based on Cardiac Damage - Changes After AVR

Mitral Annular Ring Dehisence Between Initial TTE and Pre-AVR Intraop TEE

Surveying the Present and Future Landscape of AVR Therapy: A Patient-Centered Focus

Valve-in-Valve TAVR vs Redo Surgical AVR for Bioprosthetic Aortic Valve Dysfunction

Frailty in Older Adults Undergoing AVR:The FRAILTY-AVR Study

Pitfalls in TAVR for Failing Stentless St. Jude Toronto 27mm Bioprosthetic AVR With Severe Aortic Insufficiency and No Significant Valvular Calcification

Case: 84 you Male with Porcine AVR 15 years ago and Moderate AR

Incidence and Consequence of Prosthesis-Patient Mismatch After Surgical AVR

Current Indications for TAVR: When Is TAVI Better Than Surgical AVR?

FFR in the setting of CABG and AS/AVR/TAVR

Debate: Should All Low-Risk Patients With Severe Aortic Stenosis Who are Suitable Be Allowed to Choose TAVR Rather than Surgical AVR, Without Further Trial Evidence? Con Position

Debate: Should All Low-Risk Patients With Severe Aortic Stenosis Who are Suitable Be Allowed to Choose TAVR Rather than Surgical AVR, Without Further Trial Evidence? Pro Position

Debate: TAVR for Low Risk Patients Is It time? NO, We Dont Yet Know if Its as Durable as Surgical AVR!

Three-Year Outcomes in High-Risk Patients Who Underwent Surgical or Transcatheter AVR

Thats How I Do It: Antegrade Dissection/Reentry With a 6 French System

Outcome and Impact of AVR in Patients With Preserved LVEF and Low-Gradient Aortic Stenosis (AS)

Valve-in-Valve TAVR: Changing the approach to initial AVR surgery?

Mechanical AVR and Root Replacement: When indicated?

Conventional AVR and Root Replacement: Bioprosthetic options

The Importance of Correct Valve Sizing in Surgical and Transcatheter AVR

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content